Tempest Therapeutics Statistics
NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.287-0.0189 (-6.18%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tempest Therapeutics by the numbers
Tempest Therapeutics has a market capitalization of $5.7 million based on 20.00M shares outstanding. With trailing EPS of $-3.16, Tempest Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 54.1% below its 50-day average and 78.4% below its 200-day average.
Average daily trading volume is 2.56M shares, or about $734,945 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TPST valuation vs. peer median
| Metric | TPST | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.74M | $5.75M | -0% |
| Avg. volume | 2.56M | 106.32K | +2308% |
Peer median across 8 companies: LGVN, XCUR, TOVX, ENVB, UPC, ADXN, CNSP, ACXP.
Valuation
- Market cap
- $5.74M
- EPS (TTM)
- $-3.16
- Shares outstanding
- 20.00M
Price and trading
- Previous close
- 0.3059
- Open
- 0.2967
- Day range
- 0.2803 – 0.2968
- 52-week range
- 0.28 – 4.22
- 52-week change
- -91.80%
- 50-day moving average
- 0.6251
- Beta
- —
- Volume
- 145.31K
- Average volume
- 2.56M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 5.74M
- Forward Pe
- -0.59
- Eps
- -3.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.22
- Week52 Low
- 0.28
- Avg Volume
- 2.56M
- Shares Outstanding
- 20.00M
- Ma50
- 0.63
- Ma200
- 1.33
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -93.20%
- Pct From52w Low
- 2.50%